Betty Hamilton, MD, Associate Director of the Blood and Marrow Transplant (BMT) Program at Cleveland Clinic joins the Cancer Advances podcast to talk about managing chimeric antigen receptor (CAR) T-cell therapy and other novel cellular therapies within different cancer programs to support participation in and expansion of new clinical trials.
